Browsing Caprisa (Centre for the Aids programme of research in South Africa) by Title
Now showing items 423-442 of 448
-
Understanding and responding to HIV risk in young South African women: clinical perspectives.
(South African Medical Association., 2015)Abstract available in pdf. -
Understanding methods for estimating HIV-associated maternal mortality.
(Hindawi Publishing Corporation., 2011)The impact of HIV on maternal mortality and more broadly on the health of women, remains poorly documented and understood. Two recent reports attempt to address the conceptual and methodological challenges that arise in ... -
Understanding the experiences of doctors who undertake elective surgery on HIV/AIDS patients in an area of high incidence in South Africa.
(NISC & Taylor & Francis, 2010)This study investigates the experiences of doctors who perform elective surgical procedures in an area of South Africa with a high incidence of HIV and AIDS. A qualitative study approach was adopted. Interviews were ... -
Understanding the profile of tuberculosis and Human Immunodeficiency Virus Coinfection : insights from expanded HIV surveillance at a tuberculosis facility in Durban, South Africa.
(Hindawi Publishing Corporation., 2014)Expanded HIV surveillance in TB patients forms part of the World Health Organization framework for strategic collaborative activity. Surveillance helps understand the epidemiology of the local dual epidemic and enables ... -
Unusual presentation of extrapulmonary tuberculosis: a case report on mammary tuberculosis.
(South African Medical Association., 2011)This case study highlights an unusual manifestation of extrapulmonary tuberculosis (TB) in a person living with HIV, namely mammary TB. Clinicians practising in settings where HIV and TB are endemic need to be aware ... -
Urine lipoarabinomannan to monitor antituberculosis therapy response and predict mortality in an HIV-endemic region: a prospective cohort study.
(BMJ., 2015)Abstract available in pdf. -
Using mHealth for HIV/TB treatment support in Lesotho : enhancing patient–provider communication in the START study.
(Wolters Kluwer Health., 2017)Abstract available in pdf. -
Using mobile technology (pMOTAR) to assess reactogenicity: protocol for a pilot randomized controlled trial.
(JMIR Publications., 2018)Abstract available in pdf. -
Utility of colposcopy in a phase 2 portion of a microbicide clinical trial of BufferGel and 0.5% PRO 2000 Gel.
(BioMed Central / International AIDS Society., 2012)Background: The majority of new HIV infections are acquired through heterosexual transmission. There is urgent need for prevention methods to compliment behavior change and condom use. Topical microbicide represent a ... -
Utility of Tuberculosis directly observed therapy programs as sites for access to and provision of antiretroviral therapy in resource-limited countries.
(The Infectious Diseases Society of America., 2004)The overwhelming share of the global human immunodeficiency virus (HIV) infection and disease burden is borne by resource-limited countries. The explosive spread of HIV infection and growing burden of disease in these ... -
Utilizing nucleic acid amplification to identify acute HIV infection.
(Lippincott Williams & Wilkins., 2006)No abstract available. -
V2-directed vaccine-like antibodies from HIV-1 infection identify an additional K169-binding light chain motif with broad ADCC activity.
(Cell Press., 2018)Abstract available in pdf. -
Vaginal bacteria modify HIV tenofovir microbicide efficacy in African women.
(American Association for the Advancement of Science., 2017)Abstract available in pdf. -
Vertical T cell immunodominance and epitope entropy determine HIV-1 escape.
(American Society for Clinical Investigation., 2012)HIV-1 accumulates mutations in and around reactive epitopes to escape recognition and killing by CD8+ T cells. Measurements of HIV-1 time to escape should therefore provide information on which parameters are most important ... -
Viral escape from HIV-1 neutralizing antibodies drives increased plasma neutralization breadth through sequential recognition of multiple epitopes and immunotypes.
(Plos., 2013)Identifying the targets of broadly neutralizing antibodies to HIV-1 and understanding how these antibodies develop remain important goals in the quest to rationally develop an HIV-1 vaccine. We previously identified a ... -
Viral variants that initiate and drive maturation of V1V2-directed HIV-1 broadly neutralizing antibodies.
(Nature Publishing Group., 2015)Abstract available in pdf. -
Virological and Immunological Factors Associated with HIV-1 Differential Disease Progression in HLA-B*58:01-Positive Individuals.
(American Society for Microbiology., 2010)Molecular epidemiology studies have identified HLA-B*58:01 as a protective HIV allele. However, not all B*58:01-expressing persons exhibit slow HIV disease progression. We followed six HLA-B*58:01-positive, HIV subtype ... -
Virological features associated with the development of broadly neutralizing antibodies to HIV-1.
(Elsevier Ltd., 2015)Abstract available in pdf. -
When to start antiretroviral therapy during tuberculosis treatment?
(Lippincott Williams & Wilkins., 2012)Purpose of review. Effective treatment exists for tuberculosis (TB) and for HIV, but treating both diseases simultaneously presents several challenges. This review assesses the evidence for the timing of antiretroviral ...